Access to Prescribed Medicines That May Not Be Readily Available in Kenya
Bioniche Limited supports patients, caregivers, healthcare providers and hospitals through a structured Named Patient Programme designed to facilitate access to prescribed medicines that may not be routinely available in Kenya. This includes orphan drugs, oncology medicines, rare disease therapies, hard-to-find medicines, paediatric formulations and other specialty healthcare products.
Our role is to support responsible access through prescription verification, documentation review, product sourcing, regulatory guidance and coordinated supply. We work closely with healthcare professionals to help patients receive the medicines they need while following all applicable regulatory and quality requirements.
What Is a Named Patient Programme?
A Named Patient Programme (NPP) enables access to a prescribed medicine for an individual patient when the product is unavailable through normal local supply channels or requires special sourcing. Each request is reviewed individually to determine product availability, documentation requirements and the most appropriate access pathway.
Bioniche Limited does not prescribe medicines or replace the clinical judgment of healthcare professionals. Our programme begins after a qualified doctor has prescribed the required treatment.
Who We Support
Our Named Patient Programme is designed for:
- Patients with valid prescriptions
- Caregivers seeking access to prescribed medicines
- Oncologists and specialist physicians
- Hospitals and cancer centres
- Pharmacies and healthcare facilities
- Healthcare procurement teams
Medicines We Support
Our programme may assist with access to:
- Oncology medicines
- Orphan and rare disease medicines
- Hard-to-find medicines
- Immunotherapies
- Targeted therapies
- Renal and transplant medicines
- Paediatric formulations
- Dysphagia-friendly oral formulations
- Selected specialty pharmaceuticals
Availability depends on manufacturer supply, documentation, regulatory requirements and final approval where applicable.
Named Patient Request Process
Medical Disclaimer
Named-patient access is subject to prescription verification, clinical documentation, product availability, PPB requirements, permit processing, quality review and final approval where applicable. Bioniche Limited does not guarantee product availability until sourcing, documentation and regulatory checks are complete.